P. Souverein

First name
P.
Last name
Souverein
Schultze, A., Martin, I., Messina, D., Bots, S., Belitser, S., Carreras-Martínez, J., et al. (2024). A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases. Vaccine, 42, 3039-3048. http://doi.org/10.1016/j.vaccine.2024.03.043
View
van den Dries, C. J., Pajouheshnia, R., van den Ham, H. A., Souverein, P., Moons, K. G. M., Hoes, A. W., et al. (2022). Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15534
View
van Veelen, A., Abtahi, S., Souverein, P., Driessen, J. H. M., Klungel, O. H., Dingemans, A. C., et al. (2022). Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors. Cancer Epidemiol, 78, 102149. http://doi.org/10.1016/j.canep.2022.102149
View
Been, J. V., Szatkowski, L., van Staa, T. P., Leufkens, H. G., van Schayck, O. C., Sheikh, A., et al. (2015). Smoke-free legislation and the incidence of paediatric respiratory infections and wheezing/asthma: interrupted time series analyses in the four UK nations. Sci Rep. http://doi.org/10.1038/srep15246
View
Brauer, R., Ruigomez, A., Downey, G., Bate, A., Rodriguez, L. A. G., Huerta, C., et al. (2016). Prevalence of antibiotic use: a comparison across various European health care data sources. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3831
View
Afonso, A., Schmiedl, S., Becker, C., Tcherny-Lessenot, S., Primatesta, P., Plana, E., et al. (2016). A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-016-2071-8
View
Stolk, L. M., de Vries, F., Ebbelaar, C., de Boer, A., Schalekamp, T., Souverein, P., et al. (2017). Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13264
View
Ahmadizar, F., Souverein, P., de Boer, A., & van der Zee, A. H. M. -. (2018). Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13482
View
Scheepers, L., Burden, A. M., Arts, I. C. W., Spaetgens, B., Souverein, P., de Vries, F., & Boonen, A. (2018). Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/key155
View
Ibanez, L., Sabate, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., et al. (2019). Incidence of Direct Oral Anticoagulant use in patients with non-valvular atrial fibrillation and characteristics of users in six European countries (2008-2015): A cross-national drug utilization study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14071
View